Literature DB >> 24097113

Ventricular remodeling in heart failure with preserved ejection fraction.

Amil M Shah1.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) is common, increasing in prevalence, and causes substantial morbidity and mortality. HFpEF has commonly been viewed as an expression of advanced hypertensive heart disease, with a cardiac phenotype characterized by an increase in wall thickness-to-chamber radius ratio (concentric hypertrophy). However, marked clinical heterogeneity within this syndrome is now well appreciated, and is mirrored in the variability in left ventricular (LV) structure. A review of larger imaging studies from epidemiology and clinical trial cohorts demonstrate that while concentric LV remodeling is common, it is by no means universal and many patients demonstrate normal LV geometry or even an eccentric pattern. More detailed assessment of cardiac structure and function in broader HFpEF populations will be necessary to better define the prevalence, determinants, and prognostic relevance of these measures, which may in turn serve as a foundation to identify pathophysiologically relevant sub-phenotypes within this diverse syndrome.

Entities:  

Mesh:

Year:  2013        PMID: 24097113      PMCID: PMC4467787          DOI: 10.1007/s11897-013-0166-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  67 in total

Review 1.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

Review 2.  Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition.

Authors:  Cheuk-Man Yu; Qing Zhang; Gabriel W K Yip; Pui-Wai Lee; Leo C C Kum; Yat-Yin Lam; Jeffrey Wing-Hong Fung
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

3.  Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.

Authors:  Mark J Haykowsky; Peter H Brubaker; Jerry M John; Kathryn P Stewart; Timothy M Morgan; Dalane W Kitzman
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

4.  Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy.

Authors:  G P Aurigemma; K H Silver; M A Priest; W H Gaasch
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

5.  Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.

Authors:  R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

6.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

7.  Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.

Authors:  Miho Kawaguchi; Ilan Hay; Barry Fetics; David A Kass
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

8.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

9.  Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%.

Authors:  Kun-Lun He; Daniel Burkhoff; Wen-Xiu Leng; Zhi-Ru Liang; Li Fan; Jie Wang; Mathew S Maurer
Journal:  Am J Cardiol       Date:  2009-03-15       Impact factor: 2.778

10.  Role of left ventricular stiffness in heart failure with normal ejection fraction.

Authors:  Dirk Westermann; Mario Kasner; Paul Steendijk; Frank Spillmann; Alexander Riad; Kerstin Weitmann; Wolfgang Hoffmann; Wolfgang Poller; Matthias Pauschinger; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

View more
  18 in total

1.  Association of Intradialytic Hypertension with Left Ventricular Mass in Hypertensive Hemodialysis Patients Enrolled in the Blood Pressure in Dialysis (BID) Study.

Authors:  Amith Roy Shamir; Ameet Karembelkar; Jonathan Yabes; Yi Yao; Dana Miskulin; Jennifer Gassman; David Ploth; Lavinia Negrea; Susan Paine; Mahboob Rahman; Raymond Y Kwong; Philip Zager; Manisha Jhamb
Journal:  Kidney Blood Press Res       Date:  2018-05-30       Impact factor: 2.687

Review 2.  Primary and Secondary Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Marco Giuseppe Del Buono; Leo Buckley; Antonio Abbate
Journal:  Am J Cardiol       Date:  2018-08-03       Impact factor: 2.778

3.  Metabolic inflammation in heart failure with preserved ejection fraction.

Authors:  Gabriele G Schiattarella; Daniele Rodolico; Joseph A Hill
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

4.  Computational Modeling Studies of the Roles of Left Ventricular Geometry, Afterload, and Muscle Contractility on Myocardial Strains in Heart Failure with Preserved Ejection Fraction.

Authors:  Sheikh Mohammad Shavik; Samuel Wall; Joakim Sundnes; Julius M Guccione; Partho Sengupta; Scott D Solomon; Daniel Burkhoff; Lik Chuan Lee
Journal:  J Cardiovasc Transl Res       Date:  2021-04-29       Impact factor: 3.216

5.  Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.

Authors:  Wilson Nadruz; Erin West; Morten Sengeløv; Mário Santos; John D Groarke; Daniel E Forman; Brian Claggett; Hicham Skali; Amil M Shah
Journal:  J Am Heart Assoc       Date:  2017-10-31       Impact factor: 5.501

Review 6.  Acute heart failure.

Authors:  Mattia Arrigo; Mariell Jessup; Wilfried Mullens; Nosheen Reza; Ajay M Shah; Karen Sliwa; Alexandre Mebazaa
Journal:  Nat Rev Dis Primers       Date:  2020-03-05       Impact factor: 52.329

7.  Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone.

Authors:  Otavio R Coelho-Filho; Ravi V Shah; Tomas G Neilan; Richard Mitchell; Heitor Moreno; Raymond Kwong; Michael Jerosch-Herold
Journal:  J Am Heart Assoc       Date:  2014-06-25       Impact factor: 5.501

8.  A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.

Authors:  Valentina Sala; Stefano Gatti; Simona Gallo; Enzo Medico; Daniela Cantarella; James Cimino; Antonio Ponzetto; Tiziana Crepaldi
Journal:  Biomed Res Int       Date:  2016-05-19       Impact factor: 3.411

9.  Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.

Authors:  Jasper Tromp; Wan Ting Tay; Wouter Ouwerkerk; Tiew-Hwa Katherine Teng; Jonathan Yap; Michael R MacDonald; Kirsten Leineweber; John J V McMurray; Michael R Zile; Inder S Anand; A Mark Richards; Carolyn S P Lam
Journal:  PLoS Med       Date:  2018-03-27       Impact factor: 11.069

10.  Effect of Aqueous Extract from Descurainia sophia (L.) Webb ex Prantl on Ventricular Remodeling in Chronic Heart Failure Rats.

Authors:  Ying Luo; Zhiqiang Sun; Pengfei Hu; Yuanhong Wu; Weiwei Yu; Shuwei Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.